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Importance of Innate Immunity
and Collagen Binding Integrin 11
in TNBS-Induced Colitis
(Hemler, 1990; Springer 1992). The 1 integrins are a
family of heterodimeric proteins comprising a common
1 chain (CD29) noncovalently associated with several
different  subunits (CD49) that influence the ECM bind-
ing specificity. The 11 integrin (VLA-1 or very late
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antigen-1) is a major collagen/laminin binding integrin1Clinica di Gastroenterologia ed Endoscopia Digestiva
and has been the focus of intense research in the lastDipartimento di Medicina Clinica
few years for its role in inflammatory diseases (de Fou-Patologia Universita` di Perugia
gerolles et al., 2000a; Dustin and de Fougerolles, 2001).06122 Italy
Indeed, 11 expression is rapidly induced on the2Biogen Inc.
monocyte cell surface by bacterial endotoxin or IFN-Cambridge, Massachusetts 02142
and persistently upregulated on long-term IL-2 activated3Dipartimento di Farmacologia Sperimentale
T cells (Hemler, 1990; Rubio et al., 1995). Previous stud-Universita’ di Napoli
ies have suggested a putative role for 11 in targetingItaly
and maintaining activated monocytes and T cells at the
sites of inflammation and in regulating T cell-dependent
cytokine expression (Hemler, 1990). Indeed selectiveSummary
11 blockade with a specific monoclonal antibody
(mAb) inhibits the effector phase of inflammatory re-Inflammation occurs in the context of integrin-medi-
sponses in animal models of contact and delayed-typeated adhesive interactions of cells with their extracel-
hypersensitivity and arthritis (de Fougerolles et al.,lular matrix environment. We investigated the role of
2000a; Ianaro et al., 2000). Likewise, while 1-deficientthe collagen binding integrin 11 in a model of colitis.
mice showed no overt phenotype under resting condi-11 was expressed on lamina propria T cells and
tions (Gardner et al., 1996), they showed decreased in-monocytes during disease. Both 1 deficiency and
flammatory responses in models of hypersensitivity andanti-1 mAb treatment (prophylactic and therapeutic)
arthritis (de Fougerolles et al., 2000a).protected against colitis. In vivo 11 blockade im-
Although the pathophysiological role of 11 in hu-proved macroscopic and histologic scores, decreased
man diseases is largely unknown, its expression is in-inflammatory cytokine production, and profoundly af-
creased in a variety of chronic inflammatory settings,fected the ability of lamina propria mononuclear cells
including the rheumatoid synovia of arthritis patientsto proliferate and produce IFN- in vitro. Development
(Hemler, 1990; Bank et al., 1991; Takahashi et al., 1992),and 1-mediated inhibition of colitis can be lympho-
the lungs of sarcoidosis patients (Hemler, 1990), andcyte independent, suggesting that activated mono-
the intestine of patients with inflammatory bowel dis-cytes also represent a key 11-expressing cell type
ease (IBD) (MacDonald et al., 1990).involved in colitis. These results underscore the impor-
IBD is a family of chronic, relapsing, and tissue-tance of innate immunity and, specifically, of leuko-
destructive diseases characterized by dysfunction ofcyte/matrix interactions in regulating local inflamma-
mucosal T cells, abnormal cytokine production, cellulartory responses.
inflammation, and ultimately damage to the intestinal
lining (Fiocchi, 1998). Clinically, IBD is subdivided intoIntroduction
Crohn’s disease (CD) and ulcerative colitis (UC). Al-
though the etiology of IBD remains unknown, there is
The trafficking, activation, and retention of lymphocytes,
circumstantial evidence to link IBD to the mucosal im-
monocytes, and granulocytes, which are collectively mune system’s failure to attenuate immunity to endoge-
known as “leukocytes” within inflamed tissues, are me- nous antigen (Fiocchi, 1998). In recent years several
diated by several classes of specialized adhesion glyco- animal IBD models have been developed (Elson et al.,
proteins (Springer, 1992). Although the role of these 1995; Strober et al., 2002). While the relationship of many
adhesion molecules at the leukocyte/endothelium inter- of these models to human disease is imperfect (Elson
face has been investigated extensively, the importance et al., 1995), the hapten-induced model of colonic inflam-
of interstitial adhesive interactions within the extracellu- mation in which 2,4,6-trinitrobenzene sulfonic acid
lar matrix (ECM)–rich environment of peripheral tissues, (TNBS) is delivered intrarectally to Balb/c mice displays
in which cells must migrate and be activated, has not human CD-like features, notably predominant Th1 activ-
been well explored. These interactions play a crucial ity of the mucosal CD4T cell population and transmural
role in certain leukocyte functions, including adhesion, mononuclear inflammation (Strober et al., 2002). Intesti-
costimulation, and proliferation, and therefore are nal inflammation, in this model, is thought to develop
thought to be critically involved in the generation of as a result of covalent binding of the haptenizing agent
inflammatory responses (Hemler, 1990). Collagens rep- to autologous host proteins with subsequent immune
resent the most abundant ECM protein and the major reactivity toward TNBS-modified self-antigens. It has
cell surface receptors for collagens are integrins previously been demonstrated that several adhesion
molecules are involved in recruitment of inflammatory
cells in the colon of TNBS-treated mice (Singh et al.,4Correspondence: tony_de_fougerolles@biogen.com
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2001); however, whether 11 is required to produce inflammatory response in 1/ mice (Figures 1B–1E).
inflammation in this model of colitis is unknown. Thus, 1 gene ablation protects against development
Activation of 1 integrins on monocytes and T cells of colon inflammation in the TNBS model of colitis.
provides a potent costimulatory signal for cell activation.
Indeed, after CD3 crosslinking, which is thought to
mimic antigen engagement, signals generated by 11 Blocking mAb against 11 Integrin Protects against
binding increase T cell proliferation and cytokine (TNF- Development of TNBS-Induced Colitis
and IFN-) production (Rao et al., 2000; Dustin and de Given the protective effects observed in 1/ mice, we
Fougerolles, 2001). Since TNF- and IFN--producing tested whether blocking 1 in 1/ mice with a specific
activated CD4 T cells are thought to be responsible mAb might influence disease activity. Balb/c mice given
for driving the effector phases of inflammatory response TNBS were randomized and received no treatment
in IBD patients and this feature is reproduced in the (TNBS alone), anti-1 mAb, or isotype control mAb for
TNBS model of colitis (Fiocchi, 1998; Stober et al., 2002), 7 days after induction of the colitis. We found that mice
we have examined the role of 11 integrin in recruiting subjected to intrarectal administration of 1.5 mg/mouse
and promoting cytokine secretion from lamina propria TNBS in 50% ethanol developed a severe pancolitis and
mononuclear cells (LPMC). Using 1/mice and a func- diarrhea accompanied by extensive wasting syndrome
tion-blocking anti-1 mAb, we demonstrate that 11 (Figures 2A–2C). The colons of TNBS-treated 1/ mice
is required to generate an inflammatory response in the removed 7 days after colitis induction demonstrated
intestine and that this matrix binding protein exerts potent striking hyperemia and inflammation, whereas colons
costimulatory effects on LPMC. Through the use of SCID of control mice exposed to 50% ethanol showed no
and RAG-1/ mice, we also demonstrate that develop- macroscopic signs of inflammation. Histologic analysis
ment and 1-mediated inhibition of colitis can occur of the distal colon of mice given TNBS demonstrated a
independently of lymphocytes, suggesting that acti- transmural inflammation involving all layers of the bowel
vated monocytes also represent a key 11-expressing wall with a marked increase in the thickness of the mus-
cell type involved in colitis. These results underscore cular layer and adherence to surrounding tissues (Figure
the importance of innate immunity, and specifically, of 3B). In addition, a mixed inflammatory cell infiltrate con-
leukocyte/matrix interactions in regulating local inflam- sisting of monocytes, lymphocytes, and neutrophils was
matory responses.
observed in the lamina propria (LP), along with an en-
largement of lymphoid follicles in the colon (Figure 3B).
Results TNBS administration also resulted in a diffuse mucosal
inflammation characterized by epithelial cell loss, patchy
1-Deficient Mice Are Protected against ulceration, pronounced depletion of mucin-producing
TNBS-Induced Colitis goblet cells, and reduction of the density of the tubular
To examine the role of 11 integrin in the TNBS model glands. In contrast, histologic analysis of colons from
of colitis, we first queried if colitis would develop in mice vehicle-treated (ethanol) mice was normal (Figure 3A).
deficient in 11 integrin (Figure 1). When given to wild-
When mice were prophylactically treated with anti-1
type mice, increasing doses of TNBS resulted in more
mAb, a striking improvement of the wasting disease
severe colitis and increased mortality. Although no mor-
became apparent; anti-1 mAb-treated mice usually
tality was observed in wild-type animals exposed to 1
maintained their initial body weight, whereas controlmg TNBS, higher doses of the haptenizing agent caused
mAb-treated mice continued to lose weight (Figure 2A).significant mortality 7 days after induction of colitis (Fig-
Macroscopic and histologic grading of colons on day 7ure 1A). A severe illness characterized by bloody diar-
revealed a significant reduction of inflammatory activityrhea and severe wasting disease developed in wild-type
in animals receiving anti-1 mAb (Figures 2B and 3C).mice given 2.5 mg TNBS.1/mice were more resistant
Anti-1 mAb administration also reduced the amountto TNBS-induced lethality (Figure 1A). Indeed, even at
of infiltrating neutrophils as detected by MPO activitydoses that caused greater than 50% lethality in 1/
(Figure 2C). In contrast, treating mice with the controlmice, no mortality was seen in 1/ mice. Since these
mAb had no effect on the severity of colon damagedata demonstrated that intrarectal administration of 1.5
caused by TNBS (Figures 2A–2C and 3D).mg/mouse TNBS caused colonic inflammation but was
TNBS administration was accompanied by an in-associated with a low mortality, this dose was used in
crease in plasma (data not shown) and mucosal concen-all subsequent experiments.
trations of TNF-, IFN-, and IL-2 (Figure 2D). Likewise,Injection of TNBS to 1/ mice caused significant
expression of Th1 and Th2 type cytokines, COX-2, andinflammation as measured by the histologic score, my-
iNOS mRNA as determined by RT-PCR (Figure 2E) waseloperoxidase (MPO) activity, and IFN- levels in the
also markedly upregulated in the colon of TNBS-treatedplasma (not shown) and in the colon (Figures 1B–1D).
mice. Administration of anti-1 mAb prevented in vivoWhile IFN- has been shown to play a key role in the
induction of Th1 and Th2 cytokines caused by TNBSpathogenesis of colitis in this model, other proinflamma-
(Figures 2D and 2E). Furthermore, 1 blockade was ef-tory mediators also play a mechanistic role (Strober et
fective in preventing induction of COX-2 and iNOS, sug-al., 2002). In addition to IFN-, injection of TNBS to
gesting that anti-1 mAb treatment might have broad1/ mice caused a significant upregulation of colonic
antiinflammatory activity. In contrast, the control mAbexpression of TNF-, IL-2, IL-10, COX-2, and iNOS as
failed to inhibit inflammatory cytokine protein or mRNAassessed by RT-PCR (Figure 1E). In contrast, intrarectal
administration of TNBS failed to stimulate a comparable upregulation caused by TNBS (Figures 2D and 2E).
Integrin 11 Regulates Intestinal Inflammation
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Figure 1. Deficiency of 1 Protects against Development of TNBS-Induced Colitis
Balb/c 1/ and 1/ mice were given TNBS intracolonically. Bars represent the mean  SE of 6–8 mice; one of three representative
experiments is shown. (A) The survival rate of 1/ mice was significantly higher than that of 1/ mice. *P  0.01 versus 1/. (B and C)
The severity of TNBS-induced inflammation (microscopic damage score and MPO activity) is reduced in 1/ mice as compared to 1/
mice. *P  0.01 versus control (intrarectal ethanol) mice; **P  0.01 versus 1/. (D) 1 gene ablation significantly reduced mucosal IFN-
protein content in colons of TNBS-treated mice as compared to TNBS-treated 1/ mice. *P  0.01 versus control (intrarectal ethanol) mice;
**P  0.01 versus 1/. (E) Mucosal mRNA expression of TNBS-induced inflammatory mediators is reduced in 1/ mice. 1/ and 1/
mice were treated with ethanol (C) or TNBS and mucosal levels of Th1 and Th2 cytokines, COX and NOS isoenzymes measured by RT-PCR.
M, molecular masses; -, negative control (water); , positive control (mediator-positive cDNA).
In Vivo Blockade of 11 Results in Lamina Propria from LPMC. As shown in Figure 4B, LPMC obtained
from 1/ TNBS-treated mice produced significantlyMononuclear Cells with Reduced Ability to Produce
IFN- and Proliferate more IFN- than control (ethanol-treated) mice. In vitro
activation of LPMC, through exposure to anti-CD3/anti-In the next series of studies, we determined the effect
of in vivo 11 blockade on the in vitro ability of LPMC CD28 mAb, caused a further increase in the amount of
IFN- generated (Figure 4B). The increased capacity ofto produce IFN- and proliferate. First, flow cytometry
analysis from 1/ mice demonstrated that 11 was TNBS-exposed LPMC to produce IFN- both spontane-
ously and upon in vitro activation is characteristic ofexpressed on LPMC isolated from naive animals and
that expression of this integrin was markedly increased the fact that TNBS-induced colitis is a Th1-mediated
inflammation (Strober et al., 2002). In contrast, LPMCin animals exposed to TNBS (Figure 4A). As expected,
expression of 1 was undetectable in 1/ mice. Dual- obtained from TNBS-treated mice receiving anti-1 mAb
generated significantly lower amounts of IFN- evencolor flow cytometry demonstrated that the isolated
LPMC consisted mostly of monocytes along with some after in vitro activation with anti-CD3/anti-CD28 (Figure
4B). Confirming a role for 11 in regulating cytokineCD4 T cells and that 1 was well expressed by both
cell populations (data not shown). The cellular composi- secretion in this model of colitis, LPMC obtained from
1/ mice treated with TNBS generated no detectabletion of LPMC isolated from TNBS-treated wild-type and
1/ mice was similar, though the number recovered amount of IFN- under normal culture conditions and
produced markedly decreased levels of IFN- in re-for each cell type was reduced in the 1/ mice. By
using cell lineage markers in combination with Annexin- sponse to the CD3/CD28 stimulation (Figure 4B). No
differences were seen in the total number of cells recov-V and propidium iodine staining, we also determined
that no differences exist in the rate of apoptosis between ered after in vitro culture that could account for the
dramatic differences seen in IFN- production, espe-the two groups for any of the cell types studied (data
not shown). cially given that IFN- production was normalized to the
number of cells recovered after 48 hr. Only upon CD3/We next determined the effect of in vivo 1 mAb treat-
ment or 1 gene ablation on IFN- cytokine production CD28 stimulation was there marked expansion and a
Immunity
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Figure 2. Anti-1 mAb Therapy Prevents TNBS-Induced Colitis in 1/ Mice
Balb/c wild-type mice were given 1.5 mg TNBS intracolonically and 1 mg/kg s.c. daily of either control mAb or anti-1 mAb. Bars represent
the mean  SE of 8–12 mice; one of three representative experiments is shown. (A) Wasting disease in mice with TNBS colitis is improved
by anti-1 mAb treatment. Shown are weight changes in mice 7 days after exposure to 50% ethanol alone (control) or to TNBS. *P  0.01
versus control mice; **P  0.01 versus TNBS alone. (B and C) Severity of TNBS-induced inflammation (microscopic damage and MPO activity)
is reduced by anti-1 mAb treatment. *P  0.01 versus control mice; **P  0.01 versus TNBS alone. (D) Anti-1 mAb treatment reduces colon
content of Th1 type cytokines. *P  0.001 versus control; **P  0.001 versus TNBS alone. (E) Mucosal mRNA expression of TNBS-induced
proinflammatory mediators is inhibited in mice treated with anti-1 mAb. Symbols are as described in Figure 1.
difference in cell numbers between groups—while primed LPMC obtained from mice treated in vivo with
anti-1 mAb were resistant to stimulation induced byLPMC from all groups proliferated in response to CD3/
CD28, the numbers of wild-type LPMC increased by fibronectin alone or fibronectin plus anti-CD3 (Figures
4C and 4D).100%–150%, and LPMC derived from mice in which the
11 function was blocked in vivo (mAb or knock-out)
expanded by only 40%–60% (data not shown). Thus, TNBS-Colitis Can Be Induced in the Absence
of Lymphocytes and Is Still Inhibitedthese studies indicate that in addition to decreased
IFN- production in vivo, 1 blockade results in LPMC by Anti-1 mAb
Since 11 integrin can be expressed on both activatedthat are hypo-responsive and have a significantly re-
duced in vitro capacity to produce IFN-, even after T lymphocytes and monocytes (Hemler, 1990; Rubio et
al., 1995; de Fougerolles et al., 2000a), it was importantpotent T cell stimulation.
Given that matrix proteins have been shown to have to define the cell type that is responsible for 11-medi-
ated inhibition of TNBS-colitis. To address whether Tpotent costimulatory activity on leukocytes (Shimizu and
Shaw, 1991), we carried out in vitro studies to ascertain cells are important in TNBS-colitis, and to directly exam-
ine whether these cells are important in mediating thewhether ECM could also exert costimulatory effects on
LPMC. While neither immobilized type I collagen nor beneficial effects of 1 immunoneutralization, we exam-
ined the effect of anti-1 mAb treatment in mice lackingfibronectin stimulated Th1 cytokine production or prolif-
eration of LPMC prepared from control (ethanol-treated) both T and B lymphocytes (SCID, RAG-1/). Surpris-
ingly, both SCID and RAG-1/ mice developed colitismice, incubation of TNBS-primed LPMC with fibronectin
and collagen (not shown) resulted in a significant in- in response to TNBS that was roughly comparable in
severity to that seen in wild-type mice (Figure 5). Admin-crease of IFN- production and [3H]-thymidine incorpo-
ration (Figures 4C and 4D). These effects were further istration of TNBS to SCID and RAG-1/ resulted in mor-
tality and loss of body weight equal to that seen in Balb/cenhanced when incubation was carried out in wells
coated with anti-CD3 mAb and fibronectin (Figures 4C mice (Figures 5A and 5B), and histologic analysis of
colons from these mice demonstrated a significant de-and 4D). Thus, attachment to ECM proteins can exert
a costimulatory effect on TNBS-primed LPMC. TNBS- gree of inflammation (Figure 5C). Likewise, TNBS-
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85% decrease in IFN- production. Dual-color immuno-
histochemistry was also performed on colons from nor-
mal and TNBS-treated mice and examined for infiltrating
monocytes/granulocytes and 11 integrin expression
(Figure 6). Consistent with previous reports (Belkin et
al., 1990), 11 was highly expressed on smooth muscle
cells within the colon. Colons of mice exposed to ethanol
only showed very few infiltrating granulocyte/monocytes
(CD11b) (Figure 6A). In contrast, mice with TNBS-induced
colitis showed extensive infiltration of granulocyte/mono-
cytes (Figure 6C), which was substantially reduced upon
treatment with anti-1 mAb (Figure 6B). Expression of
1 integrin was found on a subset of CD11b cells (Fig-
ure 6D); further delineation of this population revealed
expression of 11 to be restricted to monocytes
(CD11b Gr1) (data not shown).
Anti-1 mAb Treatment Reduces Colitis Severity
in Mice with Established DiseaseFigure 3. Treatment with Anti-1 mAb Results in Histologic Im-
provement in Balb/c Mice with TNBS-Induced Colitis Finally, we wanted to investigate if anti-1 mAb treat-
Colitis induction and treatment with mAb was as described in Figure ment would be effective during later phases of the dis-
2; after 1 week mice were sacrificed and paraffin sections of distal ease when colitis was fully established. Administration
colon were stained with H&E. Bar represents 50 m. (A) Normal of anti-1 or control mAb was started on day 21 and
transparietal colon section of a vehicle-treated (ethanol alone) continued for 2 weeks. As illustrated in Figure 7A, a
mouse (	200). (B) Transparietal colon section after the induction of
striking reversal in weight loss was observed in the anti-colitis by TNBS. Thickening of the colon wall, with a predominant
1 mAb-treated animals, while the control mAb wasinflammatory infiltrate in the lamina propria, and necrosis extending
deeply into the muscular and serosal layers is evident (	200). (C) ineffective. Furthermore, anti-1 mAb treatment re-
Transparietal colonic section of mice treated with TNBS plus anti- duced the severity of colitis and MPO activity (Figures
1 mAb. Only minor subepithelial edema with no inflammatory infil- 7B and 7C). Lastly, therapeutic treatment with anti-1
trate in the mucosa and submucosa is seen (	200). (D) Transparietal mAb also significantly reduced colonic expression (not
colonic section of mice treated with TNBS plus control mAb. Muco-
shown) and content of Th1 cytokines, such as IFN-,sal, submucosal, and muscular inflammatory infiltrate involving
TNF-, and IL-2 (Figure 7D).50% of the specimen, is visible (	200).
Discussion
Intrarectal administration of TNBS in mice induces ainduced increases in MPO activity and mucosal IFN-
levels were seen regardless of the presence of lympho- transmural inflammation of the colon that is due to an
IL-12-driven, Th1 T cell-mediated response to TNBS-cytes (Figures 5D and 5E). Even in the absence of lym-
phocytes, administration of blocking anti-1 mAb to haptenated colonic proteins and/or crossreactive lumi-
nal antigens (Strober et al., 2002). On this basis, TNBS-SCID and RAG-1/ mice abrogated inflammation in-
duced by TNBS, resulting in a complete protection induced colitis has been considered an experimental
model of Crohn’s disease, which is similarly character-against the wasting syndrome, histologic changes, and
neutrophil recruitment (Figures 5B–5D). Furthermore, ized by transmural inflammation, granulomas, and pro-
duction of cytokines (IL-2, IL-12, IFN- and TNF-) indic-anti-1 mAb decreased IFN- production in the colon
of TNBS-treated SCID and RAG-1/ mice (Figure 5E); ative of a Th1 response. Colitis induced by TNBS
responds favorably to many of the current therapies forthese data were also confirmed by RT-PCR (data not
shown). IBD including 5-aminosalicylic acid, glucocorticoids and
anti-TNF- antibodies (Neurath et al., 1997; Palmen etGiven that the protective effect of anti-1 mAb was
maintained in the absence of T and B cells, these results al., 1998; Wallace et al., 1999; Fiorucci et al., 2001),
providing an exceptionally useful model to test antiin-suggest that the inhibitory effect of 1 blockade is inde-
pendent of lymphocytes and is most likely mediated by flammatory therapies.
In this study we have addressed the role 11 integrin,monocytes. To directly examine what effect1 blockade
has on monocyte function, freshly isolated LP mono- a cell surface receptor for collagen/laminin, in the TNBS-
model of colitis. Previous work using anti-1 mAb dem-cytes from TNBS-treated wild-type and 1-deficient
mice were analyzed for secretion of TNF- and IFN- onstrated that 11 integrin mediates inflammatory
responses in models of contact hypersensitivity, de-(Figure 5F). Loss of 11 resulted in a decrease in the
percent of infiltrating monocytes secreting TNF- (92% layed-type hypersensitivity, and arthritis (de Fougerolles
et al., 2000a; Ianaro et al., 2000). In these models, 1WT, 73% KO) and IFN- (51% WT, 11% KO) as well as
a decrease in the amount of cytokines being produced gene disruption or 1 immunoneutralization with a spe-
cific mAb protects against disease development andper cell (mean fluorescence intensity of cytokine-secre-
ting cells: TNF- [1132 WT, 384 KO], IFN- [67 WT, 41 reduces disease severity. In the present study we have
provided evidence that 1-mediated adhesive interac-KO]). The combination of these two factors results in
around a 75% decrease in TNF- production and an tions between the ECM and emigrated leukocytes regu-
Immunity
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Figure 4. Lamina Propria Mononuclear Cells Isolated from TNBS-Treated Mice following 11 Blockade Have Reduced Cytokine Production
and Proliferative Capacity
Colitis induction and treatment groups are as in Figures 1 and 2; after 7 days mice were sacrificed and LPMC isolated and purified as described
in Experimental Procedures. (A) Integrin 11 is expressed on LPMC and increased following TNBS treatment. LPMC were obtained from
control-treated mice (intrarectal ethanol) mice (red and blue lines) or from TNBS-treated mice (green line). Cells were labeled with either
hamster isotype control mAb (red) or anti-1 mAb (blue, green), and followed by FITC anti-hamster Ig secondary reagent. Expression of 11
was analyzed by flow cytometry; one of three representative experiments is shown. (B) In vitro Th1 cytokine production from TNBS-primed
LPMC is impaired by in vivo 11 blockade. LPMC were isolated from either 1/ or 1/ mice following 7 day administration of TNBS or
ethanol (control); 1/ mice receiving TNBS were either treated with TNBS alone or in combination with control mAb or anti-1 mAb. Isolated
LPMC cells for each of these groups were cultured for 48 hr in the presence or absence of anti-CD3 and anti-CD28 mAb. Culture supernatants
were analyzed for IFN- production by ELISA. Data are mean  SE of six experiments. *P  0.001 versus cells incubated in the absence of
anti-CD3/anti-CD28 mAb; **P  0.001 versus TNBS alone; ***P  0.001 1/ versus 1/. (C and D) In vivo treatment with anti-1 mAb
inhibits IFN- release and proliferation of TNBS-primed LPMC in response to fibronectin and anti-CD3 mAb. LPMC were obtained 7 days
after colitis induction (TNBS-primed LPMC) from mice that received no mAb, control mAb, or anti-1 mAb. Isolated LPMC from each of these
groups were cultured for 48 hr (cytokine production) or 72 hr (proliferation) in either uncoated wells or wells coated with fibronectin alone or
fibronectin plus anti-CD3 mAb. Basal cytokine production and proliferation of unactivated LPMC was measured by culturing LPMC isolated
from ethanol-treated (control; naive LPMC) in uncoated wells. Culture supernatants were analyzed by ELISA for IFN- and cell proliferation
was measured by thymidine incorporation. Data are mean  SE of six experiments. *P  0.01 versus TNBS-primed untreated LPMC.
late the effector phase of colonic inflammation. In sup- a dramatic improvement of the macroscopic and histo-
logical signs of inflammation. The decreased inflamma-port of this view, we not only demonstrated that 1 gene
disruption abrogates colitis development but also that tion seen in mice treated with the anti-1 mAb was
similar to the degree of inhibition seen in the1-deficientthe effector T lymphocytes and monocytes infiltrating
the LP of colitic mice stained positively for 11 and mice confirming, in a mAb-independent manner, the im-
portance of 11-mediated interactions in colonic in-that expression of 11 was upregulated in mice given
intrarectal TNBS. Furthermore, colitis was successfully flammation.
The improvement in colitis score seen in mice treatedtreated by injecting mice with an anti-1 mAb. Indeed,
anti-1 mAb treatment not only prevented colitis devel- with anti-1 mAb (approximately 80%) compares favor-
ably to that seen with other anti-cytokine therapies, suchopment, but when administered therapeutically to ani-
mals already showing clear evidence of mucosal inflam- as anti-IL-4 (Boirivant et al., 1988), anti-IL-12 (Neurath
et al., 1995), and anti-TNF-mAbs (Neurath et al., 1997),mation, we found an abrogation of wasting disease with
Integrin 11 Regulates Intestinal Inflammation
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Figure 5. Development of TNBS-Induced Colitis Is Not Dependent on Lymphocytes and Is Still Inhibited by Anti-1 mAb Therapy
Mice (10/group) were treated with 2 mg/mouse of TNBS and observed for 7 days. One of three representative experiments is shown. (A) Wild-
type, SCID, and RAG-1/ Balb/c mice demonstrate similar sensitivity to a sublethal dose of TNBS. (B–E) Anti-1 mAb treatment protects
SCID and RAG-1/ against wasting disease (B), colon inflammation (C), neutrophil recruitment in the colon (D), and IFN- production (E)
induced by intrarectal administration of TNBS. (B, D, and E) *P  0.01 versus untreated and **P  0.01 versus TNBS. (C) *P  0.01 versus
TNBS alone. (F) Production of proinflammatory cytokines, TNF- and IFN-, by LP monocytes in response to TNBS is decreased in 1/
mice as compared to wild-type 1/ Balb/c mice. Data are shown as contour plots with the boxed region denoting monocytes staining
positive for intracellular cytokine. The number in each plot indicates the percentage of cytokine-producing LP monocytes; isotype control
mAbs gave less 1% positive-staining.
and anti-1 mAb was significantly more effective in pre- ability to induce TNBS-colitis in lymphocyte-deficient
mice does not argue that T cells are not important inventing colitis development than prednisolone (5 mg/kg
daily) or mesalamine (100 mg/kg), two drugs that are the initiation and development of disease, but rather
that disease can also develop through interaction withwidely used in treating IBD patients (Wallace et al., 1999;
Fiorucci et al., 2002). Furthermore, blockade of 11 in other cell types. Since 11 integrin is expressed on
both infiltrating LP T lymphocytes and monocytes, andTNBS-induced colitis resulted in dramatic decreases in
the expression of a wide panel of inflammatory cytokines given that the protective effect of anti-1 mAb was main-
tained in the absence of lymphocytes, these results sug-in vivo. Taken together, these findings highlight the im-
portance of 11-mediated interactions in initiating and gest that monocytes play a key role in the induction
and maintenance of colitis in this model. Furthermore,maintaining a persistent local Th1 response in the colon
of TNBS-treated mice. analysis of infiltrating LP monocytes in TNBS-colitis re-
vealed that loss of 11 had a direct inhibitory effectTNBS-colitis has often been thought of as a Th1 in-
flammatory disease requiring T cell activation as a cen- on proinflammatory cytokine production by these cells.
Increasing evidence in other models of IBD, includingtral initiating event that then leads to macrophage re-
cruitment and activation (Strober et al., 2002). The rat TNBS, also support a central role for non-T cells in
development of colitis (Dieleman et al., 1994; Hoffmannevidence that CD4 T cells play a major role in the
initiation and perpetuation of TNBS colitis is based on et al., 2001). Last, consistent with monocytes playing
an important role in mouse TNBS-colitis are the largethe Th1 cytokine response as seen after CD3/CD28 stim-
ulation of LP T cells and the attenuating effects of numer- numbers of infiltrating CD11b cells seen in the colons
of TNBS-treated mice and the marked decreased in theirous T cell-directed immunotherapies (anti-IL-12 mAb,
anti-CD40L, anti-IFN- mAb) (Neurath et al., 1995; numbers following 11 blockade (mAb treatment or
knockout).Strober et al., 2002). While the requirement for T cells
in the pathogenesis of TNBS-induced colitis is compel- There are several potential mechanisms by which anti-
1 mAb therapy can modulate the effector phase ofling, it has not been directly proven. Our results using
SCID and RAG-1/ mice clearly indicate that colitis can TNBS colitis. Indeed, disruption of integrin/matrix inter-
actions can affect leukocyte function at least at threebe induced in mice in the absence of lymphocytes. The
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Figure 6. TNBS-Induced Colitis Results in Accumulation of Granulocytes/Monocytes that Is Significantly Inhibited by Treatment with Anti-1
mAb
Immunohistochemical staining of colonic cross-sections from wild-type mice 7 days after receiving intracolonic administration of either 50%
ethanol alone (control) (A) or 1.5 mg TNBS (B–D). Mice either received no treatment (A), anti-1 mAb (B), or control mAb (C and D) as described
in Figure 2. Dual immunofluorescent staining on colon tissue was performed with Alexa488-conjugated anti-1 mAb and PE-conjugated anti-
CD11b mAb (specific for granulocytes/monocytes). No staining was seen with Alexa488- and PE-conjugated isotype control mAbs (not shown).
Magnification 	100 (A–C) and 	400 (D).
levels: recruitment of leukocytes into the inflamed tissue that 1-gene ablation and treatment with anti-1 mAb
abrogates in vivo generation of Th1 and Th2 cytokines,(endothelial/leukocyte adhesion), migration of 11-
bearing inflammatory cells through the ECM of inflamed as well as a variety of inflammatory mediators (COX-2
and iNOS). This broad antiinflammatory effect is consis-tissue, and, priming, activation, and survival of leuko-
cytes via ligation to matrix proteins. Disruption of endo- tent with the hypothesis that 11 is required for priming
and activation of colon leukocytes within the matrix-richthelial/leukocyte adhesion as a possible mechanism is
ruled out because 11 is a collagen and laminin recep- peripheral tissue environment (Dustin and de Fouge-
rolles, 2001). For example, 1 integrin-mediated bindingtor with no known ligands on endothelial cells (Hemler,
1990). The possibility that 1 blockade might negatively to collagen provides a costimulatory signal for T cell
activation, resulting in increased proliferation and secre-affect cell migration within the colon ECM is intriguing. In
vitro studies indicate that 11 is important in regulating tion of proinflammatory cytokines, such as TNF- and
IFN- (Miyake et al., 1994; Rao et al., 2000). In addition,cell movement as this integrin has been shown to be
critically involved in controlling cell migration on colla- other matrix proteins, such as fibronectin, have also
been published to have potent costimulatory activity ongen matrices (Gardner et al., 1996; Gotwals et al., 1996).
Supporting a role for 11 in leukocyte trafficking, treat- leukocytes (Shimizu and Shaw, 1991). The importance
of matrix in the inflammatory cascade is also under-ment with anti-1 mAb in an intestinal graft-versus-host
disease model not only partially prevented mucosal pa- scored by gene expression data demonstrating that
integrin-mediated attachment of monocytes to ECMthology but also showed reduced donor lymphocytic
infiltration into the intestinal mucosa (Tanaka et al., resulted in increased expression of numerous inflamma-
tory and immune response genes important in promot-1995). Similarly, in our TNBS-colitis model, blockade of
11 resulted in fewer infiltrating LP T cells and mono- ing cell recruitment and activation (de Fougerolles et al.,
2000b). In this study, we provide further proof for thecytes. While recruitment and/or retention of cells in the
LP may be in part regulated by 11, it is also clear importance of matrix proteins in providing stimulatory
signals to leukocytes, as attachment to either collagenthat 11 plays an important role in cell activation and
cytokine production. or fibronectin resulted in potent activation and prolifera-
tion of LPMC.Perhaps one of the most striking aspects of the find-
ings reported in the present study is the demonstration Not only does 11 antagonism result in decreased
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Figure 7. Anti-1 mAb Treatment Abrogates Established Colitis Present in Balb/c Mice 21 Days after TNBS Administration
Balb/c mice were given 1.5 mg TNBS intracolonically, and starting 21 days later received no treatment or 1 mg/kg of either anti-1 or control
mAb. Mice were treated daily for 2 weeks and then sacrificed. (A) Wasting disease in mice with established TNBS colitis is improved by anti-
1 mAb treatment. (B and C) Severity of TNBS-induced inflammation (microscopic damage and MPO activity) is reduced by therapeutic anti-
1 mAb treatment. (D) Treatment of established colitis with anti-1 mAb reduces colon content of Th1 type cytokines. In each panel, data
are mean  SE of 6–8 animals. *P  0.01 versus mice treated with TNBS alone.
Th1 cytokine production in vivo, but it also abrogates monocytes as compared to wild-type monocytes. Taken
together with the decreased cytokine production seenthe responsiveness of LMPC to subsequent in vitro stim-
ulation. The decreased production of IFN- and de- in the anti-1 mAb-treated SCID and RAG-1/ mice,
these results suggest that 11 is a major regulatorycreased ability of LPMC to proliferate is not a conse-
quence of defective adhesion or differences in rates of molecule for both monocytes and lymphocytes in the
intestine. Supporting this view, while 1-gene ablationapoptosis, and in fact, is specific to cells residing in the
collagen-rich lamina propria environment, as spleno- causes no major abnormalities in gut morphology, LP
lymphocytes are reduced by approximately 50% incytes from TNBS-treated 1-deficient and wild-type
mice are equally capable of responding to T cell receptor 1/ mice when compared to wild-type mice (Meharra
et al., 2000). On these bases, we postulate that the abilitystimulation and producing IFN- (A.D.F., unpublished
data). This hyporesponsiveness of LPMC provides a po- of anti-1 mAb to protect and/or treat TNBS-colitis and,
by extension, other Th1 colitides, is due at least partiallytential mechanistic explanation for the decreased in-
flammatory cytokine production seen in vivo following to its effect on cytokine-producing LPMC.
In conclusion, the present study provides evidence11 blockade. Production of inflammatory cytokines
such as IFN- and TNF- has been shown through ge- that the collagen binding integrin 11 mediates inflam-
mation in a mouse model of TNBS-induced colitis. Thenetic deletion, overexpression, and mAb studies to play
a central and pathogenic role in the development of importance of 11 is underscored by the dramatic ef-
fects that both mAb-based inhibition and genetic dele-colitis (Neurath et al., 1995, 1997; Strober et al., 2002).
The decreased responsiveness of in vivo anti-1 mAb- tion of 11 has on this model of colitis. That the devel-
opment and 1-mediated inhibition of colitis wastreated LPMC and of 1-deficient LPMC to CD3/CD28
stimulation suggests that 11 interaction with matrix independent of lymphocytes suggests that activated
monocytes represent a key 11-expressing cell typecan affect T cell activation. Blockade of 11 impacts
not only activation and cytokine production by T cells, involved in the development of colitis in this model. By
demonstrating the importance of 11 in regulating Th1but also directly affects monocytes as well. Production
of proinflammatory cytokines, IFN- and TNF-, during responses, this study suggests that 11-mediated ad-
hesive interactions play a major role in regulating localTNBS-colitis was significantly reduced in 11-deficient
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density, thickening of the colon wall; 4, transmural infiltrations, lossimmune responses. Through disruption of ECM-gener-
of goblet cells, high vascular density, thickening of the colon wall) inated signals, anti-1 mAb therapy downregulates a
a blinded fashion by a certified pathologist using a BX60 microscopebroad spectrum of inflammatory mediators, establishing
(Olympus Co., Tokyo, Japan). Thickness of the colon wall was deter-
11 as a novel target for adhesion-based therapy in mined on cross-sections by measuring the distance from the serosal
IBD. surface to the luminal surface at 2 mm intervals along the entire
length of each section.
For immunohistochemical staining, freshly isolated colonic tissueExperimental Procedures
from the distal portion of the colon was frozen in dry ice using O.C.T.
compound (Sakura, Torrance, CA). Acetone-fixed frozen sectionsMice
(10 m thick) were blocked in 3% BSA/PBS for 30 min at roomSix- to eight-week-old Balb/c female mice, SCID and RAG-1/ mice
temperature, washed, and incubated with 5g/ml Alexa 488-labeledwere obtained from Charles River (Monza, Italy). 1/ Balb/c mice
anti-1 mAb and 5 g/ml PE-conjugated anti-CD11b mAb in 3%have been previously described (Gardner et al., 1996). The study
BSA/PBS for 1 hr at room temperature. Slides were then washedprotocol was approved by the Animal Study Committees of the
in PBS and mounted in Citifluor (Ted Pella Inc., Redding, CA). TheUniversity of Perugia according to governmental guidelines for ani-
stained sections were examined by dual immunofluorescent micros-mal care.
copy (Leica, Wetzlar, Germany).
Monoclonal Antibodies
Cytokine and MPO AssaysFunction-blocking Ha31/8 mAb (hamster anti-mouse1) and isotype
Plasma and mucosal IL-2, IFN-, and TNF- concentrations werecontrol mAb Ha4/8 (hamster anti-KLH) were prepared as previously
determined by ELISA (Endogen, Woburn, MA). Neutrophil infiltrationdescribed in an azide-free and low-endotoxin format (de Fougerolles
in the colon was monitored by measuring MPO activity using aet al., 2000a). For immunohistochemistry, Ha31/8 and Ha4/8 mAbs
spectrophotometric assay with tri-methylbenzidine (TMB) as a sub-were fluorescently labeled using the Alexa 488 protein labeling kit
strate according to a previously published method (Fiorucci et al.,(Molecular Probes Inc., Eugene, OR); phycoerythrin (PE)-conjugated
2001).mAb’s, M1/70 (rat anti-CD11b) and RB6-8C5 (rat anti–Ly-6G/Gr-1),
were from PharMingen (San Diego, CA).
Reverse Transcriptase Polymerase Chain Reaction
Mice were sacrificed and the colons were removed and immediatelyInduction of Colitis and Study Design
snap-frozen on liquid nitrogen and stored at –80
C until used. TotalColitis was induced in Balb/c mice as previously described (Neurath
RNA was isolated using TRIzol reagent (Life Technologies, Milan,et al., 1995). In brief, mice were fasted for 1 day, anesthetized, and
Italy) as previously described (Fiorucci et al., 2001). PCR was per-a 3.5 F catheter inserted into the colon such that the tip was 4 cm
formed using specific primers. The sense and antisense primersproximal to the anus. To induce colitis, 1.0-2.5 mg of TNBS (Sigma
were obtained from Stratagene (La Jolla, CA; -actin, IFN-, TNF-,Chemical Co, St Louis, MO) in 50% ethanol was administered via
IL-2, IL-10), Sigma Genosys (Lid, UK; COX-1, COX-2, cNOS), orcatheter into the lumen using a 1 ml syringe (injection volume of
Maxim Biotech (San Francisco, CA; iNOS). The cDNA was amplified100 l); control mice received 50% ethanol alone. Animals were
with a “hot start” reaction (20 l) containing 5 l cDNA product, 2monitored daily for appearance of diarrhea, loss of body weight,
l PCR buffer (200 mM Tris-HCl [pH 8.4] and 500 mM KCl), 200 Mand survival. At the end of the experiment, surviving mice were
dNTP’s, 1 M each of sense and anti-sense primers, 1.5 mM MgCl2,sacrificed, blood samples collected by cardiac puncture, and a 7
1 U Platinum Taq polimerase (Life Technologies, Milan, Italy), andcm segment of colon was excised, weighed, and evaluated for mac-
water in a Hybaid PCR Sprint thermocycler (Celbio, Milan, Italy).roscopic damage. Tissue segments were then used for LPMC isola-
PCR was carried out for 35 cycles (30 for amplification of -actin)tions, immunohistochemical studies, and cytokine and MPO activity
as follows: 94
C for 30 s, 60
C for 15 s, and 72
C for 30 s, with ameasurements.
final extension at 72
C for 5 min. PCR products were separated onTo examine whether 1 gene ablation protects against colitis,
a 1.5% agarose gel and band intensity quantitated using Kodak1/ and 1/ Balb/c mice were injected intrarectally with 50%
Digital Science ID Image Analysis Software (Kodak Co, Milan, Italy).ethanol or 1.0, 1.5, 2.0, or 2.5 mg TNBS. To assess whether blockade
Each assay was carried out in triplicate. The -actin primers wereof 11 could protect against development of colitis, Balb/c mice
used as a control for both reverse transcription and the PCR reactionreceiving 1.5 mg TNBS were randomized and received either no
itself.treatment (i.e., TNBS alone), anti-1 mAb, or isotype control mAb.
To investigate the role of monocytes and lymphocytes on protection
exerted by anti-1 mAb, SCID and RAG-1/ mice were treated by Isolation of Lamina Propria Mononuclear Cells
intracolonic injection of TNBS (2 mg), alone or in combination with LP cells were isolated from freshly obtained colonic specimens
the anti-1 mAb. mAbs were given s.c. following TNBS injection using a modification of a described technique (van der Heijden and
and daily thereafter for 7 days at a dose of 1 mg/kg. Mice were Stok, 1987). In brief, after excision of all visible lymphoid follicles,
sacrificed at day 7 and their colons analyzed. Last, to address colons were washed in calcium- and magnesium-free HBSS and
whether anti-1 mAb treatment was beneficial in treating estab- treated with 1 mM EDTA in PBS for 20 min to remove the epithelium.
lished colitis, administration of the anti-1 mAb was started 3 weeks The tissue was then digested with type IV collagenase (Sigma) for
after colitis induction (1.5 mg TNBS). Balb/c mice were treated s.c. 20 min in a shaking incubator at 37
C; this step was repeated twice.
daily for 2 weeks (day 21–35) with 1 mg/kg of either anti-1 mAb The released cells were then layered on a 40%–100% Percoll gradi-
or control mAb. At day 35, mice were sacrificed and their colons ent (Pharmacia, Upsala, Sweden) and spun at 1,800 rpm to obtain
analyzed. the leukocyte-enriched population at the 40%–100% interface.
Culture of LPMC for Assay of Cytokine ProductionMacroscopic and Histologic Grading of Colitis
Colons were examined under a dissecting microscope (	5) and LPMC from the different treatment regimens were suspended in
complete medium (RPMI 1640, 10% heat-inactivated FCS, 3 mMgraded for macroscopic lesions on a scale from 0 to 10 based on
criteria reflecting inflammation, such as hyperemia, thickening of L-glutamine, 10 mM Hepes buffer, 10 g/ml gentamycin, 100 U/ml
penicillin, 100 U/ml streptomycin, and 0.05 mM 2-ME) and culturedthe bowel, and the extent of ulceration (Fiorucci et al., 2001). For
histologic examination, a colon specimen located precisely 2 cm at a concentration of 106 cells/ml. To measure cytokine production,
106 LPMC were placed for 48 hr onto uncoated culture wells (toabove the anal canal was obtained, fixed in 10% buffered formalin
phosphate, embedded in paraffin, sectioned, and stained with he- measure production by unstimulated cells) or onto wells containing
immobilized murine anti-CD3 antibody (clone 145-2C11; Phar-matoxylin and eosin (H&E). Inflammation on microscopic cross-sec-
tions was graded semiquantitatively from 0 to 4 (0, no signs of Mingen) and 1 g/ml soluble anti-CD28 (clone 37.51; PharMingen)
(to measure production by stimulated cells). Culture supernatantsinflammation; 1, very low level of inflammation; 2, low level of leuko-
cyte infiltration; 3, high level of leukocyte infiltration, high vascular were harvested and assayed for cytokine concentration by ELISA
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(Endogen). To investigate whether ECM proteins exert a costimula- binding integrins 11 and 21 in models of hypersensitivity and
arthritis. J. Clin. Invest. 105, 721–729.tory effect on LPMC, in some experiments cells were placed in wells
coated with either 10 g fibronectin (Sigma) alone or fibronectin de Fougerolles, A.R., Chi-Rosso, G., Bajardi, A., Gotwals, P., Green,
plus anti-CD3, and after 48 hr culture supernatants were assayed C.D., and Koteliansky, V.E. (2000b). Global expression analysis of
for IFN- production. All data were normalized to the final number extracellular matrix-integrin interactions in monocytes. Immunity 13,
of cells after 48 hr. Plates used in these studies were 24-well Costar 749–758.
plates (Costar Corp., Cambridge, MA); coating with anti-CD3 anti-
Dieleman, L.A., Ridwan, B.U., Tennyson, G.S., Beagley, K.W., Bucy,body was accomplished by exposing wells to a solution containing
R.P., and Elson, C.O. (1994). Dextran sulfate sodium-induced colitisanti-CD3 antibody (10 g/ml) in carbonate buffer (pH 9.6) overnight
occurs in severe combined immunodeficient mice. Gastroenterol-at 4
C.
ogy 107, 1643–1652.
Dustin, M.L., and de Fougerolles, A.R. (2001). Reprogramming TLPMC Proliferation
cells: the role of extracellular matrix in coordination of T cell activa-LPMC proliferation was assessed as previously described (Fiorucci
tion and migration. Curr. Opin. Immunol. 13, 286–290.et al., 2001). In brief, LPMC (5 	 105/well) were cultured in 96-well
microtiter plates for 72 hr. After incubation with appropriate agents Elson, C.O., Sartor, R.B., Tennyson, G.S., and Riddell, R.H. (1995).
(see above), cultures were pulsed for 7 hr with [3H] thymidine (0.5 Experimental models of inflammatory bowel disease. Gastroenterol-
Ci/well) (New England Nuclear, Boston, MA), harvested on glass ogy 109, 1344–1367.
fiber filters, and counted for radioactivity in a liquid scintillation Fiocchi, C. (1998). Inflammatory bowel disease: etiology and patho-
system. Recombinant IL-2 (200 U/ml) (Endogen) was added to cul- genesis. Gastroenterology 115, 182–205.
tures as a stimulant.
Fiorucci, S., Mencarelli, A., Palazzetti, B., Distrutti, E., Vergnolle, N.,
Hollenberg, M.D., Wallace, J.L., Morelli, A., and Cirino, G. (2001).Evaluation of 1 Expression on LPMC
Proteinase-activated receptor (PAR)-2 is an anti-inflammatory signalLPMC obtained from animals treated in different ways were isolated
for colonic lamina propria lymphocytes in a mouse model of colitis.as described, incubated with 10 g/ml primary antibody (Ha4/8 or
Proc. Natl. Acad. Sci. USA 98, 13936–13941.Ha31/8), washed, and resuspended in FITC-conjugated anti-ham-
Fiorucci, S., Antonelli, E., Distruti, E., Del Soldato, P., Flower, R.J.,ster Ig secondary antibody (PharMingen). Cells were then fixed with
Clark, M.J.P., Morelli, A., Perretti, M., and Ignarro, L.J. (2002). NCX-3.7% formaldehyde and analyzed on an EPIC XL flow cytometer
1015, a nitric-oxide derivative of prednisolone, enhances regulatory(Beckman-Coulter).
T cells in the lamina propria and protects against 2,3,6-trinitroben-
zene sulfonic acid-induced colitis in mice. Proc. Natl. Acad. Sci.Cytokine Production by LP Monocytes
USA 99, 15770–15775.LPMC were obtained and purified from TNBS-treated wild-type and
1-deficient mice as described above. LPMC were cultured for 4 hr Gardner, H., Kreidberg, J., Koteliansky, V., and Jaenisch, R. (1996).
in complete medium containing 2 M monensin. After culture, cells Deletion of integrin alpha 1 by homologous recombination permits
were washed, kept on ice, and monocytes stained using FITC anti- normal murine development but gives rise to a specific deficit in
CD11b (Pharmingen). Cells were then washed, fixed, permeabilized, cell adhesion. Dev. Biol. 175, 301–313.
and stained for intracellular cytokines (APC anti-TNF- or APC anti- Gotwals, P.J., Chi-Rosso, G., Lindner, V., Yang, J., Ling, L., Fawell,
IFN-) as recommended by the manufacturer (Pharmingen). Last, S.E., and Koteliansky, V.E. (1996). The a1b1 integrin is expressed
cells were fixed and analyzed by flow cytometry. during neointima formation in rat arteries and mediates collagen
matrix reorganization. J. Clin. Invest. 97, 2469–2477.
Data Analysis
Hemler, M.E. (1990). VLA proteins in the integrin family: structures,All values in the figures and text are expressed as mean  SE.
functions, and their role on leukocytes. Annu. Rev. Immunol. 8,The variation between data sets was tested with ANOVA, and the
365–400.significance was tested with unpaired t tests, with a Bonferroni
Hoffmann, J.C., Peters, K., Henschke, S., Herrmann, B., Pfister, K.,modification for multicomparison of data. Differences were consid-
Westermann, J., and Zeitz, M. (2001). Role of T lymphocytes in ratered significant when P was 0.05.
2,4,6-trinitrobenzene sulphonic acid (TNBS) induced colitis: in-
creased mortality after  T cell depletion and no effect of  T cellAcknowledgments
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